Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

18.2%

2 terminated/withdrawn out of 11 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

27%

3 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3

3(42.9%)

N/A

3(42.9%)

Phase 2

1(14.3%)

7Total

Phase 3(3)

N/A(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT03248557Completed

Prognostic Value of Ventricular Fibrillation Spectral Analysis in Sudden Cardiac Death

Role: collaborator

NCT03114618Completed

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient

Role: collaborator

NCT05251012Completed

3D-QFR in Non-selected Angiographic Stenosis. A Spanish Multicentre Study.

Role: collaborator

NCT03803891Unknown

Endoscopic Full-Thickness Resection In Colon

Role: collaborator

NCT02681432Phase 3Unknown

Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer

Role: collaborator

NCT02776046Not ApplicableUnknown

Individualized Perioperative Open-lung Ventilatory Strategy With High Versus Conventional Inspiratory Oxygen Fraction (iPROVE-O2).

Role: collaborator

NCT03251365Phase 2Unknown

Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer

Role: lead

NCT02158923Not ApplicableCompleted

Individualized Perioperative Open Lung Ventilatory Strategy

Role: collaborator

NCT01271114Phase 3Terminated

Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension

Role: lead

NCT01794247Phase 3Terminated

Intrathecal Magnesium for Same-day-surgery

Role: lead

NCT01217151Not ApplicableCompleted

Perioperative Hemodynamic Optimization Using the NICOM Device

Role: collaborator

All 11 trials loaded